These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

344 related articles for article (PubMed ID: 240891)

  • 21. Synergy between T cell-replacing factor and bacterial lipopolysaccharides (LPS) in the primary antibody response in vitro: a model for lipopolysaccharide adjuvant action.
    Jacobs DM
    J Immunol; 1979 Apr; 122(4):1421-6. PubMed ID: 376717
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune depression in trypanosome-infected mice. III. suppressor cells.
    Pearson TW; Roelants GE; Pinder M; Lundin LB; Mayor-Withey KS
    Eur J Immunol; 1979 Mar; 9(3):200-4. PubMed ID: 156120
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effect of activated T amplifier cells on B cells responding to thymus-independent type 1 and type 2 antigens.
    Braley-Mullen H
    J Immunol; 1982 Aug; 129(2):484-9. PubMed ID: 6979573
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune depression in trypanosome-infected mice. II. Characterization of the spleen cell types involved.
    Roelants GE; Pearson TW; Tyrer HW; Mayor-Withey KS; Lundin LB
    Eur J Immunol; 1979 Mar; 9(3):195-9. PubMed ID: 156119
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune competence of splenic lymphocytes following graft-vs-host disease in mouse allogeneic radiation chimeras.
    Urso P; Gengozian N
    J Immunol; 1977 Feb; 118(2):657-61. PubMed ID: 14214
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The capacity of microsomally-activated cyclophosphamide to induce immunosuppression in vitro.
    Shand FL
    Immunology; 1978 Dec; 35(6):1017-25. PubMed ID: 33118
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Regulation of alloantigen-induced cytotoxic responses by concanavalin A-activated lymphoid cells: suppression by antigen elimination.
    Kastner DL; Rich RR
    J Immunol; 1978 Nov; 121(5):1732-7. PubMed ID: 712063
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro responses of CBA/N mice: spleen cells of mice with an X-linked defect that precludes immune responses to several thymus-independent antigens can respond to TNP-lipopolysaccharide.
    Mosier DE; Scher I; Paul WE
    J Immunol; 1976 Oct; 117(4):1363-9. PubMed ID: 789772
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effect of graft-versus-host reaction on the immune response to alloantigens and growth of a syngeneic tumor.
    Zaleski M
    Exp Hematol; 1975 Jan; 3(1):12-21. PubMed ID: 238866
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modulation of F1 cytotoxic potentials by GvHR. Host- and donor-derived cytotoxic lymphocytes arise in the unirradiated F1 host spleens under the condition of GvHR-associated immunosuppression.
    Kubota E; Ishikawa H; Saito K
    J Immunol; 1983 Sep; 131(3):1142-8. PubMed ID: 6604089
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Polyclonal B cell activation by a B cell differentiation factor, B151-TRF2. III. B151-TRF2 as a B cell differentiation factor closely associated with autoimmune disease.
    Dobashi K; Ono S; Murakami S; Takahama Y; Katoh Y; Hamaoka T
    J Immunol; 1987 Feb; 138(3):780-7. PubMed ID: 3543118
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Immunomodulation by low-dose methotrexate. I. Methotrexate selectively inhibits Lyt-2+ cells in murine acute graft-versus-host reactions.
    Gibbons JJ; Lucas J
    J Immunol; 1989 Mar; 142(6):1867-73. PubMed ID: 2784139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of murine cytomegalovirus on the in vitro responses of T and B cells to mitogens.
    Selgrade MK; Ahmed A; Sell KW; Gershwin ME; Steinberg AD
    J Immunol; 1976 May; 116(5):1459-65. PubMed ID: 178797
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Analysis of murine T lymphocyte markers during the early phases of GvH-associated suppression of cytotoxic T lymphocyte responses.
    Hurtenbach U; Shearer GM
    J Immunol; 1983 Apr; 130(4):1561-6. PubMed ID: 6220057
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The mouse mutant "motheaten." II. Functional studies of the immune system.
    Sidman CL; Shultz LD; Unanue ER
    J Immunol; 1978 Dec; 121(6):2399-404. PubMed ID: 363947
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Graft-vs-host reactions in F1 mice induced by parental lymphoid cells: nature of recruited F1 cells.
    Romano TJ; Ponzio NM; Thorbecke GJ
    J Immunol; 1976 Jun; 116(6):1618-23. PubMed ID: 5562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of sister chromatid exchanges in spleen and thymus lymphocytes from AKR, C57BL/6N x DBA/2J F1, and CBA mice following in vivo exposure to N-methyl-N-nitrosourea.
    Neft RE; Schol HM; Casciano DA
    Cancer Res; 1989 Aug; 49(16):4504-8. PubMed ID: 2787206
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vivo immune response suppression by the supernatant from concanavalin A-activated spleen cells.
    Reinertsen JL; Steinberg AD
    J Immunol; 1977 Jul; 119(1):217-22. PubMed ID: 326957
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Natural suppressor (NS) activity from murine neonatal spleen is responsive to IFN-gamma.
    Maier T; Holda JH
    J Immunol; 1987 Jun; 138(12):4075-84. PubMed ID: 2953798
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Loss of proliferative capacity and T cell immune development potential by bone marrow from mice undergoing a graft-vs-host reaction.
    Iwasaki T; Fujiwara H; Iwasaki T; Shearer GM
    J Immunol; 1986 Nov; 137(10):3100-8. PubMed ID: 2945856
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 18.